Multiple input algorithm-guided Deep Brain stimulation-programming for Parkinson's disease patients.
Eileen GülkeLeón M Juárez-PazHeleen ScholtesChristian GerloffAndrea A KühnMonika Pötter-NergerPublished in: NPJ Parkinson's disease (2022)
Technological advances of Deep Brain Stimulation (DBS) within the subthalamic nucleus (STN) for Parkinson's disease (PD) provide increased programming options with higher programming burden. Reducing the effort of DBS optimization requires novel programming strategies. The objective of this study was to evaluate the feasibility of a semi-automatic algorithm-guided-programming (AgP) approach to obtain beneficial stimulation settings for PD patients with directional DBS systems. The AgP evaluates iteratively the weighted combination of sensor and clinician assessed responses of multiple PD symptoms to suggested DBS settings until it converges to a final solution. Acute clinical effectiveness of AgP DBS settings and DBS settings that were found following a standard of care (SoC) procedure were compared in a randomized, crossover and double-blind fashion in 10 PD subjects from a single center. Compared to therapy absence, AgP and SoC DBS settings significantly improved (p = 0.002) total Unified Parkinson's Disease Rating Scale III scores (median 69.8 interquartile range (IQR) 64.6|71.9% and 66.2 IQR 58.1|68.2%, respectively). Despite their similar clinical results, AgP and SoC DBS settings differed substantially. Per subject, AgP tested 37.0 IQR 34.0|37 settings before convergence, resulting in 1.7 IQR 1.6|2.0 h, which is comparable to previous reports. Although AgP long-term clinical results still need to be investigated, this approach constitutes an alternative for DBS programming and represents an important step for future closed-loop DBS optimization systems.
Keyphrases
- deep brain stimulation
- parkinson disease
- obsessive compulsive disorder
- machine learning
- healthcare
- deep learning
- double blind
- systematic review
- randomized controlled trial
- magnetic resonance imaging
- clinical trial
- magnetic resonance
- ejection fraction
- end stage renal disease
- chronic kidney disease
- depressive symptoms
- liver failure
- physical activity
- neural network
- prognostic factors
- pain management
- contrast enhanced